Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-26-024785

Options or other derivatives

  • GC and Corporate Secretary acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bergmann Joshua Benjamin · GC and Corporate Secretary

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-08 Grant or award : show line 1 in the form Stock Option (Right to Buy) +50,000 50,000 D
Loading xslF345X06/form4.xml…